Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bertelmann

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|December 7, 2019
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN StudyJosep Callizo, Focke Ziemssen, Thomas Bertelmann, et al.
Ophthalmic Research|July 26, 2014
Intravitreal functional plasminogen in eyes with branch retinal vein occlusionThomas Bertelmann, Walter Sekundo, Stefan Strodthoff, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 8, 2020
Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center studySebastian Bemme, Peer Lauermann, Nina Antonia Striebe, et al.
Plos One|August 4, 2017
Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathyJosep Callizo, Nicolas Feltgen, Antje Ammermann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 9, 2017
The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT studyThomas Bertelmann, Joachim Wachtlin, Stefan Mennel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 6, 2018
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in GermanyFocke Ziemssen, Joachim Wachtlin, Laura Kuehlewein, et al.
Journal of Translational Medicine|March 13, 2025
Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control studyJuliane Schikora, Aaron Dort, Hannah N Wolf, et al.
Current Eye Research|November 1, 2019
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: <i>Post-hoc</i> Analysis from the COMRADE TrialsAmelie Pielen, Nicolas Feltgen, Lars-Olof Hattenbach, et al.
Retina (Philadelphia, Pa.)|January 19, 2017
VITRECTOMY FOR PERSISTENT MACULAR HOLES FOLLOWING OCRIPLASMIN INJECTION: A Comparative Multicenter StudyRicarda G Schumann, Armin Wolf, Hans Hoerauf, et al.
Retina (Philadelphia, Pa.)|November 2, 2016
IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPYChristoph Paul, Christine Heun, Hans H Müller, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Ophthalmology (Auckland, N.Z.)|December 7, 2019
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN StudyJosep Callizo, Focke Ziemssen, Thomas Bertelmann, et al.
Ophthalmic Research|July 26, 2014
Intravitreal functional plasminogen in eyes with branch retinal vein occlusionThomas Bertelmann, Walter Sekundo, Stefan Strodthoff, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 8, 2020
Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center studySebastian Bemme, Peer Lauermann, Nina Antonia Striebe, et al.
Plos One|August 4, 2017
Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathyJosep Callizo, Nicolas Feltgen, Antje Ammermann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 9, 2017
The predictability of ocriplasmin treatment effects: is there consensus among retinal experts? Results from the EXPORT studyThomas Bertelmann, Joachim Wachtlin, Stefan Mennel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 6, 2018
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in GermanyFocke Ziemssen, Joachim Wachtlin, Laura Kuehlewein, et al.
Journal of Translational Medicine|March 13, 2025
Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control studyJuliane Schikora, Aaron Dort, Hannah N Wolf, et al.
Current Eye Research|November 1, 2019
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: <i>Post-hoc</i> Analysis from the COMRADE TrialsAmelie Pielen, Nicolas Feltgen, Lars-Olof Hattenbach, et al.
Retina (Philadelphia, Pa.)|January 19, 2017
VITRECTOMY FOR PERSISTENT MACULAR HOLES FOLLOWING OCRIPLASMIN INJECTION: A Comparative Multicenter StudyRicarda G Schumann, Armin Wolf, Hans Hoerauf, et al.
Retina (Philadelphia, Pa.)|November 2, 2016
IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPYChristoph Paul, Christine Heun, Hans H Müller, et al.
Pageof 5